BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• 

  Broad Institute Embarks on Holy Grail Quest to Harness Old Compounds for Rare Diseases

  The Broad Institute of MIT and Harvard is taking bold steps to acquire samples of every drug ever developed in order to test whether or not they could be used off-label to treat other diseases than the ones for which they were manufactured.

  May 14, 2018

   · 

  2 min read

   · 

  Alex Keown
• FDA

  FDA approves additional claim for Roche cobas Zika test

  New claim allows for streamlined screening of pooled blood or plasma donations

  May 14, 2018

   · 

  5 min read
• BioArctic Extends the Research Collaboration With Uppsala University Regarding New Antibody Technology

  BioArctic AB today announced that the company has signed an extended research collaboration agreement with Uppsala University, Department of Pharmaceutical Biosciences.

  May 14, 2018

   · 

  2 min read
• Drug Development

  CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia

  Second pipeline candidate to enter Phase I studies in Australia within one month

  May 14, 2018

   · 

  4 min read
• Business

  Bruker Announces Quarterly Dividends

  Bruker Corporation (NASDAQ: BRKR) today announced payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

  May 14, 2018

   · 

  1 min read
• Business

  Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan’s Board

  Titan develops proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology.

  May 14, 2018

   · 

  4 min read
• Pharm Country

  SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)

  Complete and easy-to-use LC-MS-based solution for biotherapeutics characterization and quality testing

  May 14, 2018

   · 

  4 min read
• Business

  PAVmed and Case Western Reserve University Finalize Definitive Licensing Agreement for Groundbreaking EsoCheck Technology

  PAVmed subsidiary Lucid Diagnostics Inc. secures exclusive worldwide license for EsoCheck

  May 14, 2018

   · 

  10 min read
• Drug Development

  Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV

  Arrowhead has also dosed a total of 20 healthy volunteers since the study began on March 27.

  May 14, 2018

   · 

  3 min read
• BioCapital

  Cerner Leads “Big EMR” Market, Epic in “Small EMR” Market, Says Kalorama Information Report

  Annual report found market share changed as players dropped out.

  May 14, 2018

   · 

  3 min read